logo

CSTL

Castle Biosciences·NASDAQ
--
--(--)
--
--(--)
6.05 / 10
Outperform

Analyst sentiment is strongly bullish: one Buy recommendation (100%) and an Outperform sentiment rating. Fund‑flow score is good (7.71), yet all size categories show negative inflow trends, indicating recent capital outflows despite positive analyst views.

FundamentalSentiment(6.05)Technical
Fund Flow Rating
Analyst RatingBuy

Wall Street Opinions

Buy

Strong Buy

0%

Buy

100%

Hold

0%

Sell

0%

Strong Sell

0%

Date2026-02-27
InstitutionBaird
Times predicted2
Historical Win Rate50.0%
Is money flowing into or out of CSTL?
  • CSTL holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.05/10 (Outperform).